This study reveals the potential mechanism of Sal B in obesity-related OA, and further confirms the therapeutic value of Sal B in obesity-related diseases, thus providing a theoretical basis for clinical application of Sal B. The gene discussed is PPIB; the disease is obesity due to melanocortin 4 receptor deficiency.